Structure-based drug design with equivariant diffusion models
Arne Schneuing(École Polytechnique Fédérale de Lausanne), Bruno E. Correia(SIB Swiss Institute of Bioinformatics), Arian R. Jamasb(University of Cambridge), Michael M. Bronstein(Citigroup), Kieran Didi(University of Cambridge), Ilia Igashov(École Polytechnique Fédérale de Lausanne), Charles B. Harris(University of Cambridge), Píetro Lió(University of Cambridge), Carla P. Gomes(Cornell University), Max Welling(University of California, Irvine), Tom L. Blundell(University of Cambridge), Weitao Du(Academy of Mathematics and Systems Science), Yuanqi Du(Cornell University)
Cited by 162
Related Papers
Comparative Protein Modelling by Satisfaction of Spatial Restraints
|Journal of Molecular Biology|1993|13.2k
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
|Journal of Medicinal Chemistry|2015|5.3k
An Introduction to Variational Autoencoders
|Foundations and Trends® in Machine Learning|2019|2.5k
Scientific discovery in the age of artificial intelligence
|Nature|2023|1.6k
FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties11Edited by B. Honig
|Journal of Molecular Biology|2001|1.2k